MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.
about
Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host InteractionInnate Immunity and Immune Evasion by Enterovirus 71TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetesc-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3Diverse Strategies Used by Picornaviruses to Escape Host RNA Decay PathwaysThe adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicityThe role of sex differences in autophagy in the heart during coxsackievirus B3-induced myocarditisPolymorphisms in the innate immune IFIH1 gene, frequency of enterovirus in monthly fecal samples during infancy, and islet autoimmunityThe combination of early and rapid type I IFN, IL-1α, and IL-1β production are essential mediators of RNA-like adjuvant driven CD4+ Th1 responsesTRIM13 is a negative regulator of MDA5-mediated type I interferon production.Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation.The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3.Viral infection of engrafted human islets leads to diabetes.Selection of rhinovirus 1A variants adapted for growth in mouse lung epithelial cells.RIG-I-dependent antiviral immunity is effective against an RNA virus encoding a potent suppressor of RNAi.Melanoma differentiation-associated gene 5 is critical for protection against Theiler's virus-induced demyelinating disease.Type 1 diabetes is associated with enterovirus infection in gut mucosaCyclosporine A Treatment Inhibits Abcc6-Dependent Cardiac Necrosis and Calcification following Coxsackievirus B3 Infection in Mice.Role of specific innate immune responses in herpes simplex virus infection of the central nervous systemWild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivoEnhanced enteroviral infectivity via viral protease-mediated cleavage of Grb2-associated binder 1.Type I Interferons Triggered through the Toll-Like Receptor 3-TRIF Pathway Control Coxsackievirus A16 Infection in Young MiceMitochondrial antiviral-signalling protein plays an essential role in host immunity against human metapneumovirusOver-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production.The role of MyD88 signaling in heterosubtypic influenza A virus infections.Autoimmunity in picornavirus infections.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets.Differential induction of Toll-like receptors & type 1 interferons by Sabin attenuated & wild type 1 polioviruses in human neuronal cells.Enter at your own risk: how enteroviruses navigate the dangerous world of pattern recognition receptor signaling.In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.Type 1 diabetes: etiology, immunology, and therapeutic strategies.Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection.Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes.Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?Caspase-8 and FLIP regulate RIG-I/MDA5-induced innate immune host responses to picornaviruses.The interaction between human enteroviruses and type I IFN signaling pathway.Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.Antiviral RNA recognition and assembly by RLR family innate immune sensors.
P2860
Q26771132-6A20452A-89D9-4218-A435-A97677EE87BAQ26773329-48E52BAA-76B8-426C-9E91-7B9269EF2224Q27025559-83DF24F7-B4D6-46FB-83E1-C978AE8E95BBQ27335025-4CCA7A5D-F8BF-4FF2-A5FF-67B8B9394772Q28077216-0E01828A-DA2C-4337-B87E-2D3C8032D352Q28238832-90E8C78E-C208-4B35-AFED-3C7AE2D84CD1Q28391287-614CABD8-BCD9-49BF-8142-D26574D999C7Q34081824-3CD924FB-1DF2-4623-A07F-8282007CF7F9Q34113741-27956871-3496-41E0-8C63-F3AE4AFADADEQ34262107-7BFB9843-0EA8-4F6A-A237-3D3ECE3575FDQ34608956-7FBB74AC-EF9C-4483-843C-9D3D2403239DQ34708584-9EF5CC40-FDFF-43A2-B1C6-5243BE698F9DQ35076535-B998B2DB-08E3-480B-9A2A-E24C9D198037Q35220557-41A49E49-C39B-4D27-932C-B3B7C9E77888Q35498780-518E0881-7EB9-4A01-B254-9B95BC995495Q35588762-EBE22187-C732-493B-BAB6-8E8D7EAD8FA8Q35689719-DA15D9D9-251D-43A0-AD90-2EB2A5FCEF75Q35766884-E51D3276-60BA-44D9-8F79-512AC261B536Q35777110-38B4F7A9-DD3F-4F9E-BDC5-2948D03EBA40Q35826453-A45B4027-AA8B-4F46-AAC0-FA2A11765A55Q35981115-753942AA-AE6C-4D8C-B0FD-C3BAC63929CEQ36171284-90395A92-E884-41E4-86E8-DBA32C5A7C30Q36208204-5579E5A4-0230-4B2A-9027-850D516295B0Q36376613-4506FD44-3E7D-4BE7-9BD7-2EB5B545C5C0Q36539027-DBABFB12-0784-4279-A60A-A1D0D7DCCEA5Q36569402-0968A0BD-C40C-4FB1-BF9F-F201BCE24D3DQ36767670-E721D503-0CE4-42DC-BD72-46404A00E0F8Q36807121-DE315CDC-48ED-4080-AD98-E1A154F7C9FBQ36978822-0356FBF4-2A64-49AF-BB91-8A0591E92D81Q37210264-69D08E01-FBBC-4FD8-85FD-B9AA34C84919Q37704544-8489D3EB-1847-494E-9A63-2ACB39C71C74Q37713958-2B467CCA-92C9-4482-9F0F-02C66F9A2EDAQ37830198-9E599B76-881C-4DF6-850A-C020D5199180Q37876416-53318B4A-2FAE-438B-8DB6-1B76F8AA3C60Q37990026-F38F01E2-F8BC-4667-ACBE-D25EFBFD50E6Q38048862-FBA9663E-8BDB-4EA4-A330-493BB0622301Q38090473-C72E010B-DB6F-43F1-AAE7-D62F5CFBFBA2Q38126917-5967C72E-BD0A-4582-87BD-94FA0F1B9D38Q38156856-A959636A-BC7F-4381-B714-94340F7FF170Q38235759-0B5FAF7B-21EF-4687-9F82-6545EB8A4732
P2860
MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.
@en
MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.
@nl
type
label
MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.
@en
MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.
@nl
prefLabel
MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.
@en
MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.
@nl
P2093
P2860
P356
P1433
P1476
MDA5 and MAVS mediate type I interferon responses to coxsackie B virus
@en
P2093
Anna Cerny
Damon R Asher
Evelyn A Kurt-Jones
Robert W Finberg
Roderick T Bronson
P2860
P304
P356
10.1128/JVI.00631-09
P407
P577
2010-01-01T00:00:00Z